Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 1
2008 1
2010 3
2011 5
2012 5
2013 1
2014 4
2015 6
2016 4
2017 6
2018 3
2019 7
2020 7
2021 7
2022 3
2023 6

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer.
Leboulleux S, Bournaud C, Chougnet CN, Zerdoud S, Al Ghuzlan A, Catargi B, Do Cao C, Kelly A, Barge ML, Lacroix L, Dygai I, Vera P, Rusu D, Schneegans O, Benisvy D, Klein M, Roux J, Eberle MC, Bastie D, Nascimento C, Giraudet AL, Le Moullec N, Bardet S, Drui D, Roudaut N, Godbert Y, Morel O, Drutel A, Lamartina L, Schvartz C, Velayoudom FL, Schlumberger MJ, Leenhardt L, Borget I. Leboulleux S, et al. Among authors: zerdoud s. N Engl J Med. 2022 Mar 10;386(10):923-932. doi: 10.1056/NEJMoa2111953. N Engl J Med. 2022. PMID: 35263518 Clinical Trial.
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer.
Leboulleux S, Do Cao C, Zerdoud S, Attard M, Bournaud C, Lacroix L, Benisvy D, Taïeb D, Bardet S, Terroir-Cassou-Mounat M, Anizan N, Bouvier-Morel E, Lamartina L, Lion G, Betrian S, Sajous C, Schiazza A, Garcia ME, Ciappuccini R, Schlumberger M, Al Ghuzlan A, Godbert Y, Borget I. Leboulleux S, et al. Among authors: zerdoud s. Clin Cancer Res. 2023 Jul 5;29(13):2401-2409. doi: 10.1158/1078-0432.CCR-23-0046. Clin Cancer Res. 2023. PMID: 37074727 Clinical Trial.
Diagnosis, biology and epidemiology of oligometastatic breast cancer.
Lacaze JL, Aziza R, Chira C, De Maio E, Izar F, Jouve E, Massabeau C, Pradines A, Selmes G, Ung M, Zerdoud S, Dalenc F. Lacaze JL, et al. Among authors: zerdoud s. Breast. 2021 Oct;59:144-156. doi: 10.1016/j.breast.2021.06.010. Epub 2021 Jul 1. Breast. 2021. PMID: 34252822 Free PMC article. Review.
Brief progress report from the intersocietal working group on differentiated thyroid cancer.
Verburg FA, Ahuja S, Avram AM, Bardiès M, Bernet V, Bourguet P, Führer-Sakel D, Draganescu C, Daniels GH, Greenspan B, Gulec S, Hegedüs L, Jonklaas J, Luster M, Oyen W, Smit J, Tuttle RM, Zerdoud S, Van Nostrand D. Verburg FA, et al. Among authors: zerdoud s. Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1345-1347. doi: 10.1007/s00259-020-04744-8. Eur J Nucl Med Mol Imaging. 2020. PMID: 32166513 Free PMC article. No abstract available.
[Molecular genotyping in refractory thyroid cancers in 2021: When, how and why? A review from the TUTHYREF network].
de la Fouchardière C, Wassermann J, Calcagno F, Bardet S, Al Ghuzlan A, Borget I, Borson Chazot F, Do Cao C, Buffet C, Zerdoud S, Decaussin-Petrucci M, Godbert Y, Leboulleux S. de la Fouchardière C, et al. Among authors: zerdoud s. Bull Cancer. 2021 Nov;108(11):1044-1056. doi: 10.1016/j.bulcan.2021.06.009. Epub 2021 Sep 27. Bull Cancer. 2021. PMID: 34593218 Free article. Review. French.
"Quid autem vides festucam in oculo fratris tui et trabem in oculo tuo non vide" on the hyperthyroidism-induced mortality and antithyroid drug-induced side effects in the era of radioiodine fake news.
Giovanella L, Verburg FA, Ovčariček PP, Iakovou I, Mihailovic J, Vrachimis A, Zerdoud S, Hoffmann M, Luster M. Giovanella L, et al. Among authors: zerdoud s. Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1342-1344. doi: 10.1007/s00259-020-04748-4. Eur J Nucl Med Mol Imaging. 2020. PMID: 32157430 No abstract available.
Errare humanum est, sed in errare perseverare diabolicum: methodological errors in the assessment of the relationship between I-131 therapy and possible increases in the incidence of malignancies.
Verburg FA, Hoffmann M, Iakovou I, Konijnenberg MW, Mihailovic J, Gabina PM, Ovčariček PP, Reiners C, Vrachimis A, Zerdoud S, Giovanella L, Luster M. Verburg FA, et al. Among authors: zerdoud s. Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):519-522. doi: 10.1007/s00259-019-04580-5. Eur J Nucl Med Mol Imaging. 2020. PMID: 31807882 No abstract available.
Development of Photoonycholysis with Vandetanib Therapy.
Negulescu M, Zerdoud S, Boulinguez S, Tournier E, Delord JP, Baran R, Sibaud V. Negulescu M, et al. Among authors: zerdoud s. Skin Appendage Disord. 2017 Jan;2(3-4):146-151. doi: 10.1159/000452425. Epub 2016 Nov 3. Skin Appendage Disord. 2017. PMID: 28232923 Free PMC article.
60 results